Artal Group’s Biogen BIIB Stock Holding History

Artal Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-150,000	Closed	-$42.5M	–	98
2016 Q4	$42.5M	Hold	150,000	–	–	0.94%	13
2016 Q3	$47M	Hold	150,000	–	–	0.93%	8
2016 Q2	$36.3M	Sell	150,000 -250,000	-63%	-$65.9M	0.75%	10
2016 Q1	$104M	Buy	400,000 +50,000	+14%	+$13.2M	2.03%	5
2015 Q4	$107M	Sell	350,000 -50,000	-13%	-$14.4M	2.01%	5
2015 Q3	$117M	Buy	400,000 +50,000	+14%	+$16.5M	2.61%	4
2015 Q2	$141M	Buy	350,000 +115,000	+49%	+$46.2M	6.09%	3
2015 Q1	$99.2M	Buy	235,000 +63,000	+37%	+$24.8M	4.59%	4
2014 Q4	$58.4M	Buy	172,000 +30,000	+21%	+$9.71M	2.05%	7
2014 Q3	$47M	Buy	142,000 +42,000	+42%	+$13.8M	1.73%	11
2014 Q2	$31.5M	Buy	100,000 +25,000	+33%	+$7.52M	1.27%	16
2014 Q1	$22.9M	Buy	+75,000	New	+$23.8M	0.83%	25

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return